- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06330389
Burn Injuries During COVID-19 Pandemic and Its Influence on Length of Stay
Anesthetic Experience and Patients 'Prognosis of SARS-CoV-2 Positive Versus Negative Burns Patients: An Observational Case -Control Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
1. Introduction / History
The world is being attacked by the rapidly expanding severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) epidemic, which is exacerbating an economic crisis. SARS-Cov-2 is the cause of the coronavirus disease 2019 (COVID-19). Anaesthetists are at risk for contracting a virus while doing their regular duties because they frequently come into touch with respiratory droplets.
All nations have put protective and preventive measures in place, forcing people to spend more time at home. A Brazilian study discovered that during the COVID-19 pandemic period, spending more time at home increased exposure to sanitizing products, which include ethanol and hydrogen peroxides that can cause burn injuries.
Aim of our Study:
Our goal is to determine the risk factors that influence length of hospital stay (LOS) of burn injured patients during COVID -19 pandemic.
Inclusion Criteria:
Patients who had the burn graft surgery at Al Wakrah Hospital; Hamad Medical Corporation between from 1st of April to end of November 2020. Planned number will include all COVID-19 positive and negative subjects in this period.
Data Source The electronic medical record (Cerner) used in order to identify patients who match study defined criteria. The investigators can Collect data directly from Cerner to excel sheet
Variable Abstraction Patient demographic and clinical data will be collected including age, morbidities, presenting symptoms, physical examination, laboratory investigations, intraoperative data, type of surgery, postoperative course, survival, and length of hospital stay and follow up.
In addition, the type of anesthesia is also included as factor for further complications ex general anesthesia, spinal or combined spinal epidural type.
Observation full reviewing of their medical illness and chart laboratory and investigations will be collected after getting approval of MRC and IRB committee.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Doha, Qatar, 82228
- HAMAD Medical Corporation- Al Wakra Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All burn injuries required surgery with COVID-19 positive or negative status
Exclusion Criteria:
- Other surgery during COVID-19 pandemic
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
COVID-19 Positive and Negative status
Burn injuries with COVID-19 Positive and Negative status underwent surgery
|
Burn Injuries Graft Surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Our goal is to determine the risk factors that influence length of hospital stay (LOS) of burn injured patients during COVID -19 pandemic.
Time Frame: 60-90 days
|
Our goal is to determine the risk factors that influence length of hospital stay (LOS) of burn injured patients during COVID -19 pandemic.
|
60-90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical diffreneces between burn injuries with positive vs negative COVID-19 status
Time Frame: 60-90 days
|
Details for those risk Factors: BMI; Pre Op Lab data, Intra Op data ex. blood loss / ml, transfusions/ ml or Unit , surgery time/ min, etc, Post operative data and ICU admission data, , lab parameters, INR,LFTs/unit , required blood transfusions/ml or Unit , re intubation times, vasopressor needs. Analyze lab values /unit, check number of days in hospital stay and ICU stay . Analyze risk factors which affect hospital length of stay. Analyze risk factors using cox regression and investigate hazard ratio for each one to determine which is independent risk factor OR associated factor. |
60-90 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRC-01-20-1074
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SARS-CoV-2 Infection
-
St. Olavs HospitalThe Research Council of Norway; Helse Nord-Trøndelag HF; Alesund Hospital; Namsos... and other collaboratorsCompletedSARS-CoV-2 Acute Respiratory Disease | SARS-CoV-2 Sepsis | SARS CoV 2 InfectionNorway
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Kamuzu University... and other collaboratorsRecruitingSARS CoV 2 Infection | SARS CoV 2 VaccinationUnited States, Malawi
-
AIM Vaccine Co., Ltd.Zhejiang Provincial Center for Disease Control and PreventionNot yet recruiting
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...Not yet recruiting
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical CollegeActive, not recruiting
-
AIM Vaccine Co., Ltd.Hunan Provincial Center for Disease Control and PreventionCompleted
-
Indiana UniversityCompletedSARS-CoV-2United States
-
Peking UniversityCenters for Disease Control and Prevention, China; Beijing Pinggu District... and other collaboratorsCompleted
-
University Hospital, Montpelliersociete SkillCell - 97198 Jarry; CNRS Alcediag UMR9005 - societe Sys2Diag -...Completed
-
Centre Hospitalier Universitaire DijonCompleted
Clinical Trials on Burn Injuries Graft Surgery
-
University Hospital, LinkoepingCompleted
-
Asan Medical CenterHangang Sacred Heart HospitalCompleted
-
Groupe Hospitalier Paris Saint JosephRecruiting
-
Universidad Complutense de MadridCompleted
-
Florida Orthopaedic InstituteTerminatedFemoral Fractures | Tibial FracturesUnited States
-
Gregory GilotThe Cleveland Clinic; LifeNet HealthTerminated
-
Necmettin Erbakan UniversityDİLEK ÖZKAN ŞENActive, not recruitingFree Gingival Graft Volume ChangeTurkey
-
Aesculap AGB.Braun Surgical SACompletedCoronary Heart Disease | Multi Vessel Coronary Artery DiseasePortugal, Spain, Germany, Italy
-
Baskent UniversityRecruitingCoronary Artery DiseaseTurkey
-
University of ZurichCompleted